India to Canada: Irbesartan Export Trade Route
India has recorded 97 verified shipments of Irbesartan exported to Canada, representing a combined trade value of $2.1M USD. This corridor is served by 9 active Indian exporters, with an average shipment value of $21.5K USD. The leading Indian exporter is MARKSANS PHARMA LIMITED, which accounts for 29% of total export value with 6 shipments worth $601.4K USD. On the buying side, TEVA CANADA LIMITED is the largest importer in Canada with $777.7K USD in purchases. The top 3 suppliers — MARKSANS PHARMA LIMITED, MACLEODS PHARMACEUTICALS LTD, TEVAPHARM INDIA PRIVATE LIMITED — together control 70% of total trade value on this route. All data sourced from Indian Customs (DGFT) shipping bill records. Values reported in FOB USD.

Route Intelligence Overview
The India to Canada Irbesartan corridor is one of India's established pharmaceutical export routes, with 97 shipments documented worth a combined $2.1M USD. The route is dominated by MARKSANS PHARMA LIMITED, which alone accounts for roughly 29% of all export value, reflecting the consolidated nature of India's irbesartan manufacturing sector.
Across 9 active suppliers, the average shipment value stands at $21.5K USD — a figure that reflects both bulk commercial orders from large pharmaceutical companies and smaller specialty shipments. Sea freight dominates at 83% of all shipments, consistent with irbesartan's non-urgent bulk-order profile.
Shipment activity peaks during October–December, with an average transit time of 28 days port-to-port. The route has recorded an annual growth rate of 30.4%, placing it at rank #7 among India's top irbesartan export destinations globally.
On the import side, key buyers of Indian irbesartan in Canada include TEVA CANADA LIMITED, JAMP PHARMA CORPORATION, TEVA CANADA LIMITED and 7 others. TEVA CANADA LIMITED is the single largest importer with 7 shipments valued at $777.7K USD.
Route Characteristics
- Average transit28 days
- Peak seasonQ4
- Primary modeSea freight
- Top portDadri-ACPL CFS
Market Position
- Global rank#7
- Annual growth+30.4%
- Demand growth+25.4%
- Regulatory ease88/100
Top 10 Indian Irbesartan Exporters to Canada
Showing top 10 of 9 Indian suppliers exporting Irbesartan to Canada, ranked by total trade value (USD)
| Rank | Supplier (Indian Exporter) | Shipments | Total Value (USD) | Market Share |
|---|---|---|---|---|
| 1 | MARKSANS PHARMA LIMITED Avg $100.2K per shipment | 6 | $601.4K | 28.9% |
| 2 | MACLEODS PHARMACEUTICALS LTD Avg $26.0K per shipment | 17 | $442.6K | 21.3% |
| 3 | TEVAPHARM INDIA PRIVATE LIMITED Avg $45.1K per shipment | 9 | $405.6K | 19.5% |
| 4 | JUBILANT GENERICS LIMITED Avg $5.7K per shipment | 36 | $205.2K | 9.9% |
| 5 | MARKSANS PHARMA LTD Avg $176.3K per shipment | 1 | $176.3K | 8.5% |
| 6 | SUN PHARMACEUTICAL INDUSTRIES LIMITED Avg $9.7K per shipment | 18 | $173.7K | 8.3% |
| 7 | SUN PHARMACEUTICAL INDUSTRIES LTD Avg $9.0K per shipment | 4 | $35.9K | 1.7% |
| 8 | SUN PHARMACEUTICAL INDUSTRIES LIMITED Avg $22.9K per shipment | 1 | $22.9K | 1.1% |
| 9 | JUBILANT GENERICS LTD Avg $3.8K per shipment | 5 | $19.1K | 0.9% |
This table shows the top 10 of 9 Indian companies exporting irbesartan to Canada, ranked by total trade value. The listed exporters are: MARKSANS PHARMA LIMITED, MACLEODS PHARMACEUTICALS LTD, TEVAPHARM INDIA PRIVATE LIMITED , JUBILANT GENERICS LIMITED, MARKSANS PHARMA LTD, SUN PHARMACEUTICAL INDUSTRIES LIMITED, SUN PHARMACEUTICAL INDUSTRIES LTD, SUN PHARMACEUTICAL INDUSTRIES LIMITED , JUBILANT GENERICS LTD. MARKSANS PHARMA LIMITED is the dominant supplier with 6 shipments worth $601.4K USD, giving it a 29% market share. The top 3 suppliers together account for 70% of the total trade value on this route.
Top 10 Irbesartan Importers in Canada
Showing top 10 of 10 known buyers in Canada receiving Irbesartan shipments from India, ranked by import value
On the receiving end of this trade route, the leading importers of Indian irbesartan in Canada include TEVA CANADA LIMITED, JAMP PHARMA CORPORATION, TEVA CANADA LIMITED , WILLIAMS PHARMALOGISTIQUE INC, M/S. SUN PHARMA CANADA INC, among 10 total buyers. The largest importer is TEVA CANADA LIMITED, accounting for $777.7K USD across 7 shipments — representing 37% of all irbesartan imports from India on this route.
| Rank | Importer / Buyer | Shipments | Import Value (USD) | Market Share |
|---|---|---|---|---|
| 1 | TEVA CANADA LIMITED | 7 | $777.7K | 37.3% |
| 2 | JAMP PHARMA CORPORATION | 17 | $442.6K | 21.3% |
| 3 | TEVA CANADA LIMITED | 9 | $405.6K | 19.5% |
| 4 | WILLIAMS PHARMALOGISTIQUE INC | 25 | $137.3K | 6.6% |
| 5 | M/S. SUN PHARMA CANADA INC | 11 | $85.1K | 4.1% |
| 6 | LABORATOIRE RIVA INC | 11 | $67.9K | 3.3% |
| 7 | M S SUN PHARMA CANADA INC | 4 | $65.1K | 3.1% |
| 8 | MS SUN PHARMA CANADA INC | 7 | $59.5K | 2.9% |
| 9 | M/S. SUN PHARMA CANADA INC | 1 | $22.9K | 1.1% |
| 10 | Laboratoire Riva Inc | 5 | $19.1K | 0.9% |
Top 10 Irbesartan Formulations Imported by Canada
Showing top 10 of 85 product formulations shipped on the India to Canada Irbesartan route, ranked by trade value
Canada imports a wide range of irbesartan formulations from India, spanning tablets, capsules, suspensions, and combination drugs. The top formulation — PHARMACEUTICAL PRODUCTS -RATIO-IRBESARTAN 300MG FT.FASS F,VK,CA E BATCH NO:131518,131519,131514,131515,131516,131520,131NOS — accounts for $264.6K USD across 3 shipments. There are 85 distinct product descriptions in the dataset, reflecting the variety of dosage forms and strengths imported.
| Rank | Product Formulation | Shipments | Trade Value (USD) | Market Share |
|---|---|---|---|---|
| 1 | PHARMACEUTICAL PRODUCTS -RATIO-IRBESARTAN 300MG FT.FASS F,VK,CA E BATCH NO:131518,131519,131514,131515,131516,131520,131NOS | 3 | $264.6K | 12.7% |
| 2 | 172744, RATIO-IRBESARTAN 300 MG FT.FASS | 4 | $199.8K | 9.6% |
| 3 | PHARMACEUTICAL ARTICLE / ODS / PRODUCT / ITEM -RATIO-IRBESARTAN 150M3 FT.FASS F,VK,CA E Batch No: 131086,131034, 131083, 131084,131085 Mfg Dt | 1 | $176.3K | 8.5% |
| 4 | PHARMACEUTICAL ARTICLE / ODS / PRODUCT / ITEM -RATIO-IRBESARTAN 300MG FT.FASS FVKCA E BATCH NO-131256131257131258131259131260 MFG DT:SEP | 1 | $165.3K | 7.9% |
| 5 | 172731, RATIO-IRBESARTAN 150 MG FT.FASS | 3 | $139.1K | 6.7% |
| 6 | MEDICINE: IRBESARTAN 300MG + HYDROCHLOROTHIAZIDE 12.50MG TABLETS (Net content:584.76 kgs Irbesartan) Pack Size: 1X100 | 1 | $126.4K | 6.1% |
| 7 | PHARMACEUTICAL ARTICLE / ODS / PRODUCT / ITEM - RATIO-IRBESARTAN 150MG FT.FASS FVKCA E BATCH NO:131521131522 131523 MFG DT:NOV-2023 EXP D | 1 | $105.3K | 5.1% |
| 8 | DRUGS AND PHARMACEUTICALS HARMLESS MEDICINES - . IRBESARTAN TAB 150MG(100S)- JAMP CANADA | 1 | $92.7K | 4.4% |
| 9 | 172463, RATIO-IRBESARTAN 75 MG FT.FASS F | 2 | $66.6K | 3.2% |
| 10 | PHARMACEUTICAL ARTICLE / ODS / PRODUCT / ITEM - RATIO-IRBESARTAN 300MG FT.FASS FVKCA E BATCH NO:131492131493 MFG DT:OCT-2023 EXP DT:SEP-20 | 1 | $66.2K | 3.2% |
Showing top 10 of 85 Irbesartan formulations imported by Canada on this route.
Shipping & Logistics Analysis
Freight mode split and port-of-origin breakdown
Freight Mode Distribution
Sea freight dominates at 83%, typical for bulk pharmaceutical shipments.
Top Ports of Origin
Dadri-ACPL CFS handles the highest volume with 25 shipments. Transit time averages 28 days by sea.
Market Dynamics
India's irbesartan exports to Canada are driven primarily by a handful of large-scale manufacturers. MARKSANS PHARMA LIMITED with 6 shipments leads the pack, a pattern common in generic pharmaceutical corridors where manufacturing scale creates significant cost advantages. The presence of 9 active exporters signals a competitive but concentrated market — buyers in Canada benefit from supplier diversity while the top tier handles the majority of volume.
The top 3 suppliers — MARKSANS PHARMA LIMITED, MACLEODS PHARMACEUTICALS LTD, TEVAPHARM INDIA PRIVATE LIMITED — together account for 70% of total trade value on this route. The average shipment value of $21.5K USD reflects a mix of bulk commercial orders and smaller specialty shipments.
Beyond the primary product category, shipments on this route include closely related formulations such as 172744, ratio-irbesartan 300 mg ft.fass and pharmaceutical article / ods / product / item -ratio-irbesartan 150m3 ft.fass f,vk,ca e batch no: 131086,131034, 131083, 131084,131085 mfg dt, suggesting that buyers in Canada tend to consolidate orders across related product lines from the same Indian supplier.
On the buying side, TEVA CANADA LIMITED is the largest importer with 7 shipments worth $777.7K USD — representing 37% of all irbesartan imports from India on this route. A total of 10 buyers are active on this corridor.
Route Statistics
- Trade Volume
- $2.1M
- Avg. Shipment
- $21.5K
- Suppliers
- 9
- Buyers
- 10
- Transit (Sea)
- ~28 days
- Annual Growth
- +30.4%
Related Analysis
Reverse Direction
Canada → India — Irbesartan (Import)Other Irbesartan Routes
Unlock the Full India to Canada Irbesartan Dataset
TransData Nexus provides verified shipment-level records, supplier contact details, HS code breakdowns, real-time pricing benchmarks, and regulatory compliance guides for 97 shipments on this route.
Frequently Asked Questions — India to Canada Irbesartan Trade
Answers based on Indian Customs (DGFT) shipment records compiled by TransData Nexus
Q Which Indian companies export Irbesartan to Canada?
The leading Indian exporters of Irbesartan to Canada are MARKSANS PHARMA LIMITED, MACLEODS PHARMACEUTICALS LTD, TEVAPHARM INDIA PRIVATE LIMITED . MARKSANS PHARMA LIMITED holds the largest market share at approximately 29% of total trade value on this route.
Q What is the total value of Irbesartan exports from India to Canada?
India exports Irbesartan to Canada worth approximately $2.1M USD across 97 recorded shipments. The average value per shipment is $21.5K USD.
Q Which ports does India use to ship Irbesartan to Canada?
The most active port of origin is Dadri-ACPL CFS with 25 shipments. Indian exporters primarily use sea freight for this route, with 83% of shipments going by sea and 29% by air.
Q How long does shipping take from India to Canada for Irbesartan?
The average transit time for Irbesartan shipments from India to Canada is approximately 28 days. Sea freight typically takes longer, while air freight can reduce this significantly for urgent orders. Peak shipping activity is observed during October–December.
Q Is the India to Canada Irbesartan trade route growing?
Yes — this trade corridor has seen an annual growth rate of approximately 30.4% with demand growth tracking at 25.4%. The route is ranked #7 among India's top Irbesartan export destinations globally.
Q How many suppliers are active on the India to Canada Irbesartan route?
There are currently 9 active Indian suppliers exporting Irbesartan to Canada. The market is moderately concentrated with MARKSANS PHARMA LIMITED accounting for 29% of total shipment value.
Q Who are the main importers of Irbesartan from India in Canada?
The leading importers of Indian Irbesartan in Canada include TEVA CANADA LIMITED, JAMP PHARMA CORPORATION, TEVA CANADA LIMITED , WILLIAMS PHARMALOGISTIQUE INC, M/S. SUN PHARMA CANADA INC. TEVA CANADA LIMITED is the largest buyer with 7 shipments worth $777.7K USD.
Official References & Regulatory Resources
- India Trade Statistics (DGFT)
- Invest India — Pharma Sector
- WCO HS Nomenclature
- Ministry of Commerce — Pharma Exports
- Pharmexcil
Data sourced from Indian Customs (DGFT) records. Verify regulatory and trade status with the agencies above.
Research Methodology & Data Transparency
Suresh Sormare
Verified AuthorPharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormarePrimary Data Source
All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Analysis Methodology
- 1.Route Identification: India to Canada export trade corridor identified from Indian Customs (DGFT) records for Irbesartan.
- 2.Supplier/Buyer Matching: 9 Indian exporters and 10 importers in Canada matched using name normalization.
- 3.Value Aggregation: Total export value aggregated from 97 verified shipping bill records. Values are FOB in USD.
- 4.Market Share Analysis: Each supplier and buyer contribution calculated as a percentage of total route value. Statistical normalization applied to ensure accurate representation across varying shipment sizes.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
97 Verified Shipments
9 Indian exporters tracked
Expert-Reviewed
By pharmaceutical trade specialists